MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease

L Szabova1, K Chrysovergis, S S Yamada

  • 1Matrix Metalloproteinase Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD 20892-4380, USA.

Oncogene
|December 12, 2007
PubMed

Insights

Membrane-type I matrix metalloproteinase (MT1-MMP) is crucial for mammary cancer progression. MT1-MMP deficiency reduced tumor metastasis by 50%, highlighting its role in cancer cell dissemination.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Membrane-type I matrix metalloproteinase (MT1-MMP) is implicated in various cancers, including mammary cancer.
  • Understanding MT1-MMP's role in tumor progression and metastasis is critical for developing targeted therapies.

Purpose of the Study:

  • To investigate the direct impact of MT1-MMP deficiency on mammary tumor progression and metastasis.
  • To elucidate the mechanism by which MT1-MMP influences cancer cell dissemination.

Main Methods:

  • Generation of a genetically engineered mouse model by crossing MT1-MMP-deficient mice with MMTV-PyMT mice.
  • Orthotopic transplantation of mammary tumors into syngeneic recipient mice.
  • Assessment of tumor growth, metastasis to the lungs, and MT1-MMP expression in tumor stroma and metastatic sites.

Main Results:

  • MT1-MMP-deficient tumors showed earlier palpation and faster growth to experimental endpoint compared to wild-type tumors.
  • A significant reduction (50%) in lung metastasis was observed in MT1-MMP-deficient mice.
  • MT1-MMP was exclusively expressed in the tumor stroma, and metastatic nodules lacked MT1-MMP expression.
  • Stromal fibroblasts from MT1-MMP-deficient tumors exhibited impaired type I collagen degradation.

Conclusions:

  • Stromal MT1-MMP expression is essential for efficient mammary tumor cell metastasis.
  • MT1-MMP-mediated stromal remodeling of the tumor microenvironment is critical for cancer cell dissemination.
  • Targeting stromal MT1-MMP may represent a therapeutic strategy to inhibit cancer metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...